Avascular Necrosis of Hip

3

Review clinical trials related to Avascular Necrosis of Hip. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Effectiveness of the HIT Reverse HRS

The purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.

Participants needed: 288
Trial details
Age: 50-75Biological sex: AllType: InterventionalSponsor: Hip Innovation TechnologyUpdated: May 11, 2026Locations: 6
Eligibility criteria

Patient requires primary THA due to NIDJD or any of its composite diagnoses such... [+4]

Patient has received earlier THA, hemi-arthroplasty, or fusion in the contralate... [+20]

Status: Recruiting

Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

Participants needed: 368
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: CorinUpdated: Mar 18, 2026Locations: 4
Eligibility criteria

Both genders. [+4]

Subjects with active infection or sepsis or osteomyelitis. [+6]

Status: Recruiting

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Zimmer BiometUpdated: Jun 18, 2025Locations: 11
Eligibility criteria

Patient must be a legal adult who has reached full skeletal maturity. [+7]

Patient presents with osteoporosis, which in the opinion of the Principal Invest... [+9]